Pharma Journalist -

Boehringer Ingelheim and Eli Lilly and Company announced CAROLINA (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its primary…
Read More...

Recipharm announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe…
Read More...

Emerald Health Pharmaceuticals and Lonza have announced an agreement for the large-scale manufacturing of a new synthetic derivative of cannabidiol (CBD) and its oral drug product for…
Read More...

Merck, known as MSD outside the United States and Canada, announced the presentation of interim data from the Phase 1b/2 KEYNOTE-365 umbrella trial investigating KEYTRUDA, Merck’s…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This…
Read More...

AbCellera announced a multi-target and multi-year collaboration with Novartis. Under the agreement, AbCellera will apply its expertise in antibody discovery and its single-cell…
Read More...

SK Biopharmaceuticals and Arvelle Therapeutics GmbH announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe.…
Read More...

In less than 2 months time, the Pharmaceutical Microbiology East Coast conference will be returning to Boston, on April 10th and 11th 2019. Pharmaceutical Microbiology is constantly…
Read More...

SMi Reports: Gain the latest insights into the drug discovery field at the 3rd annual conference on Drug Discovery Chemistry, next month in London. Last month, personal invitations…
Read More...

Mayne Pharma Group Limited announced the launch of LEXETTE (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobetasol…
Read More...